Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer
Clinical trial NCT01532960 · TERMINATED
Trial details
- NCT number
- NCT01532960
- Sponsor
- Craig L Slingluff, Jr
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2015-09-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.